Company
NovoCure GmbH
NovoCure GmbH has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Pembrolizumab | Phase 3 | Metastatic Non-small Cell Lung Cancer |
Latest
No recent events.
Follow NovoCure GmbH on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.